OCULAR THERAPEUTIX INC
OCULNASDAQ🏆 #1497 by market capEarnings Nov 2 · PostUS Equity
$9.76▲ $0.55 (+5.63%)
Live1h—
24h▲ 5.6%
7d▲ 14.7%
14d▲ 16.7%
30d▼ 1.3%
1y▼ 21.8%
🏦Market Cap
$2.14B
Small Cap
📈Revenue Growth (YoY)
-8.1%
Declining
📊Gross Margin
87.1%
High
💵FCF Margin
—
⚖️P/S Ratio
38.8x
Expensive
Otter Score
62
Fair
📊
Analyst Ratings
Price
$9.76
Total
19
Raised
2
Lowered
1
Avg PT
$27.50
| Institution | Action | Rating | Date |
|---|---|---|---|
Chardan Capital | Reiterated | Buy | 2026-08-04 |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-18 |
Baird | Reiterated | Outperform | 2026-06-18 |
RBC Capital | Reiterated | Outperform | 2026-05-06 |
Needham | Reiterated | Buy | 2026-05-05 |
Clear Street | Reiterated | Buy | 2026-03-03 |
TD Cowen | Reiterated | Buy | 2025-10-30 |
Piper Sandler | Reiterated | Overweight | 2025-10-03 |
JMP Securities | Reiterated | Market Outperform | 2025-10-01 |
Scotiabank | Reiterated | Sector Outperform | 2025-08-06 |
HC Wainwright& Co. | Reiterated | Buy | 2025-05-29 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-04 |
Raymond James | Reiterated | Strong Buy | 2022-11-08 |
H.C. Wainwright | Reiterated | Buy | 2019-11-15 |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2019-05-21 |
BTIG Research | Upgraded | Neutral → Buy | 2018-01-19 |
BTIG | Upgraded | Neutral → Buy | 2018-01-19 |
Morgan Stanley | Reiterated | Equal Weight | 2017-07-14 |
Cantor Fitzgerald | Reiterated | Overweight | 2017-07-12 |
One row per institution, most recent rating